Public Joint Stock Company "ROSSETI Northern Caucasus" (MRKK.ME)
RUB 9.78
(-0.2%)
RUB 9.78
(-0.2%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.48 Billion | 141.51 Million | -4.54 Billion | -900.48 Million | -697.05 Million | -1.94 Billion |
| Net Income | 678.52 Million | -27.88 Billion | -11.39 Billion | -17.47 Billion | -7.9 Billion | -6.21 Billion |
| Depreciation & Amortization | 1.24 Billion | 1.48 Billion | 1.35 Billion | 1.69 Billion | 1.37 Billion | 1.51 Billion |
| Deferred income taxes | - | 6.9 Billion | -1.4 Billion | -2.72 Billion | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.63 Billion | 4.09 Billion | -2.95 Billion | 1.23 Billion | 2.4 Billion | 1.28 Billion |
| Other non-cash items | -8.77 Billion | 22.44 Billion | 8.44 Billion | 13.64 Billion | 5.77 Billion | 3.23 Billion |
| Investing Cash Flow | -2.96 Billion | -2.8 Billion | -2.58 Billion | -2.31 Billion | -635.31 Million | -905.54 Million |
| Investments in PPE | -3.27 Billion | -3.42 Billion | -2.67 Billion | -2.44 Billion | -855.82 Million | -986.37 Million |
| Acquisitions | - | 1.6 Million | 482 Million | 17.75 Million | 8.55 Million | 6.1 Million |
| Investment purchases | - | - | -500 Million | - | - | - |
| Sales/Maturities of investments | 2.08 Million | 518 Million | 18 Million | - | - | 74.72 Million |
| Other Investing Activities | 312.55 Million | 106.28 Million | 90.17 Million | 125.66 Million | 211.95 Million | 101.32 Million |
| Financing Cash Flow | 25.1 Billion | 4.06 Billion | 7.04 Billion | 1.35 Billion | 3.36 Billion | 1.08 Billion |
| Debt repayment | -11.4 Billion | -9.8 Billion | -1.1 Billion | -5.93 Billion | -4.7 Billion | -1.37 Billion |
| Dividends payments | - | - | - | - | - | -11 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 20.76 Billion | 6.12 Billion | 3.57 Billion | 660.67 Million | 8.06 Billion | 2.45 Billion |
| Other Financing Activities | 15.74 Billion | 7.73 Billion | 4.57 Billion | 6.63 Billion | 2.97 Billion | 6.12 Billion |
| Accounts receivables | -17.91 Billion | -8.21 Billion | -10.29 Billion | -824.45 Million | -3.33 Billion | -2.54 Billion |
| Accounts payables | 17.91 Billion | 8.21 Billion | 10.29 Billion | 824.45 Million | 3.91 Billion | 3.86 Billion |
| Inventory | -189.52 Million | -35.16 Million | -326.62 Million | 108.58 Million | -181.78 Million | -56.58 Million |
| Other working capital | -11.44 Billion | 4.13 Billion | -2.62 Billion | 1.12 Billion | 2.01 Billion | 20.17 Million |
| Cash at beginning of period | 2.64 Billion | 1.24 Billion | 1.33 Billion | 3.19 Billion | 1.16 Billion | 2.93 Billion |
| Cash at end of period | 6.3 Billion | 2.64 Billion | 1.24 Billion | 1.33 Billion | 1.68 Billion | 1.16 Billion |
| Capital Expenditure | -3.27 Billion | -3.42 Billion | -2.67 Billion | -2.44 Billion | -855.82 Million | -986.37 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.65 Billion | 1.39 Billion | -88.21 Million | -1.85 Billion | 519.63 Million | -1.77 Billion |
| Free Cash Flow | -21.75 Billion | -3.28 Billion | -7.22 Billion | -3.34 Billion | -1.55 Billion | -2.93 Billion |
| Breakdown | 2023 Q3 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.28 Billion | 9.51 Billion | 678.52 Million | -2.29 Billion | -3.66 Billion | -2.87 Billion |
| Depreciation & Amortization | - | 291.09 Million | 1.24 Billion | 297.08 Million | 252.36 Million | 393.97 Million |
| Deferred income taxes | - | - | - | -95.68 Million | 751.31 Million | -895.66 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -12.36 Billion | -11.63 Billion | 1.8 Billion | -2.71 Billion | -6.38 Billion |
| Other non-cash items | 2.28 Billion | -4.44 Billion | -8.77 Billion | -3.09 Billion | 3.29 Billion | 1.84 Billion |
| Investing Cash Flow | - | -1.58 Billion | -2.96 Billion | -198.88 Million | -978.34 Million | -290.37 Million |
| Investments in PPE | - | -1.63 Billion | -3.27 Billion | -198.93 Million | -1.07 Billion | -363.79 Million |
| Acquisitions | - | - | - | 55 Thousand | 401 Thousand | 215 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 2.08 Million | - | 2.08 Million | - |
| Other Investing Activities | - | 53.82 Million | 312.55 Million | 89.42 Million | 95.88 Million | 73.41 Million |
| Financing Cash Flow | - | 10.88 Billion | 25.1 Billion | 2.48 Billion | 3.23 Billion | 8.5 Billion |
| Debt repayment | - | -33.72 Million | -11.4 Billion | -2.51 Billion | -9.68 Billion | -8.54 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 20.76 Billion | 33.66 Million | 9.87 Billion | - |
| Other Financing Activities | - | 10.84 Billion | 15.74 Billion | 33.66 Million | 12.91 Billion | 8.5 Billion |
| Accounts receivables | - | -12.21 Billion | -17.91 Billion | -1.45 Billion | -782.32 Million | -3.46 Billion |
| Accounts payables | - | - | 17.91 Billion | 3.94 Billion | 782.32 Million | -1.48 Billion |
| Inventory | - | 42.47 Million | -189.52 Million | -30.51 Million | -249.7 Million | 48.22 Million |
| Other working capital | - | -200.13 Million | -11.44 Billion | -653.23 Million | -2.46 Billion | -6.43 Billion |
| Cash at beginning of period | - | 4.01 Billion | 2.64 Billion | 3.25 Billion | 3.83 Billion | 2.64 Billion |
| Cash at end of period | - | 6.3 Billion | 6.3 Billion | 4.01 Billion | 3.25 Billion | 3.83 Billion |
| Capital Expenditure | - | -1.63 Billion | -3.27 Billion | -198.93 Million | -1.07 Billion | -363.79 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 2.28 Billion | 3.65 Billion | 756.68 Million | -578.52 Million | 1.19 Billion |
| Free Cash Flow | - | -8.64 Billion | -21.75 Billion | -1.72 Billion | -3.9 Billion | -7.38 Billion |
SWAT
PROMAX
PMG
SRV1V
CARE
CDI